(VIANEWS) – Shares of Viking Therapeutics (NASDAQ: VKTX) slid 5.07% to $4.03 at 10:41 EST on Tuesday, after four consecutive sessions in a row of gains. NASDAQ is falling 1.36% to $14,691.13, following the last session’s upward trend. This seems, so far, an all-around down trend trading session today.
Viking Therapeutics’s last close was $4.24, 57.98% below its 52-week high of $10.09.
Today’s last reported volume for Viking Therapeutics is 198395 which is 75.15% below its average volume of 798691.
The company’s growth estimates for the ongoing quarter and the next is a negative 61.5% and a negative 46.7%, respectively.
Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.23%, a negative 0.32%, and a positive 2.75%, respectively.
Viking Therapeutics’s highest amplitude of average volatility was 3.49% (last week), 3.08% (last month), and 2.75% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be oversold (<=20).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $4.03 at 10:41 EST, way below its 52-week low of $4.81.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s worth is way under its 50-day moving average of $5.82 and way below its 200-day moving average of $6.03.
More news about Viking Therapeutics (VKTX).